ATF News & media

Here is a selection of the articles available in issue number 54 of "Thyroid News".

Does every thyroid cancer need treatment?
Professor Leigh Delbridge

There are mixed messages in the media about thyroid cancer. On one hand we hear that thyroid cancer, which up until now, had been considered a rare disorder, has shown a dramatic increase in cases worldwide with a tripling of incidence in the USA. In Australia currently, of all malignancies documented in the national cancer registries, thyroid cancer is the most rapidly increasing in females.

Please note you need to be a member to read these articles in full.

LOGIN TO READ MORE

Name change of active ingredient of Oroxine, Eutroxsig and Eltroxin to align with international terminology.

Aspen Pharma has written to the ATF (letter included in the edition). The name of the active ingredient of Oroxine, Eutroxsig and Eltroxin has been changed in Australia to align with international terminology. Thyroxine will no longer be the name of the active ingredient, it will be now known in Australia as Levo-thyroxine, which is the international reference. Please be aware when speaking to your GP, Endocrinologist or Pharmacist.

Please note you need to be a member to read these articles in full.

LOGIN TO READ MORE

INTERNATIONAL THYROID AWARENESS WEEK 2016 - 23-29 MAY 2016

WORLD THYROID DAY -  25TH MAY

The ATF is a member of Thyroid Federation International (TFI), the worldwide thyroid patient support and educational organisation.

TFI Messaging for International Thyroid Awareness Week 2016 relates to Children and Thyroid Disease.

Please head to our 'Children's section' on the ATF website and click onto the YouTube link below to view a video highlighting Children with Hypo and Hyper Thyroid Disorders.

Here is a selection of articles available in issue number 52 of "Thyroid News":

Eltroxin: a new brand of thyroxine replacement therapy is now available in Australia

Aspen, the pharmaceutical company that manufactures the only brands of thyroxine (Oroxine and Eutroxsig) that have been available in Australia has now introduced a third brand of thyroxine for therapeutic use. The new product with the brand name of Eltroxin is being imported and is widely used overseas, particularly in Europe. It has now been approved for use in Australia by the Therapeutic Goods Administration (TGA). Aspen claims that it is a new formulation and the big difference between Eltroxin and current brands is that Eltroxin does not need to be refrigerated, making it more convenient particularly for patients who may be travelling and needing to refrigerate their Oroxine or Eutroxsig medication.

Please note you need to be a member to read these articles in full.

LOGIN TO READ MORE 

How to eat gluten free the right way

10-15 years ago it was hard, very hard in fact to find gluten free foods for those individuals who needed them. The bread options were tasteless and crumbly. Snacks were virtually impossible to find and cakes and biscuits that were available were packed full of fats and calories. Fast forward till today and we now have an entire section of major supermarkets dedicated to gluten free foods; gluten free bread options are produced by the major bread makers and it is not uncommon to see gluten free menu options at popular restaurants. Food times are a changing.

Please note you need to be a member to read these articles in full.

LOGIN TO READ MORE